TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma.

Nabil Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.